Name
Chemipower OÜ
Registry code
16442800
VAT number
EE102630831
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
15.02.2022 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
21101 - Manufacture of basic pharmaceutical products
14 000 €
5 057 €
36%
-
657 €
0
Submitted
No tax arrears
770%
6%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Ants Laos
| - | - | Indirect ownership |
| Anne Laos
| - | - | Indirect ownership |
| Liivar Laos
| - | - | Indirect ownership |
| Jaanus Põder
| - | Board member | Member of a higher management body, i.e. board member or supervisory board member |
| Omanikukonto: AARE-LAIDAR LAOS
| - | Board member | Member of a higher management body, i.e. board member or supervisory board member |
| Elizabeth Põder
| 10% - 250.00 EUR | Board member | Member of a higher management body, i.e. board member or supervisory board member |
| Osaühing SILLEVER 10902442 | 50% - 1 250.00 EUR | - | - |
| Patre Investeeringud OÜ 12526061 | 40% - 1 000.00 EUR | - | - |
| 2022 04.07.2023 | 2023 26.07.2024 | 2024 04.06.2025 | |
|---|---|---|---|
| Total Revenue | - | - | 14 000 € |
| Net profit (loss) for the period | -5 314 € | -1 586 € | 5 057 € |
| Profit Margin | - | - | 36% |
| Current Assets | 7 419 € | 9 248 € | 22 660 € |
| Fixed Assets | - | 20 348 € | 66 321 € |
| Total Assets | 7 419 € | 29 596 € | 88 981 € |
| Current Liabilities | - | 7 882 € | 89 € |
| Non Current Liabilities | 10 233 € | 26 114 € | 88 235 € |
| Total Liabilities | - | 33 996 € | 88 324 € |
| Share Capital | - | - | - |
| Equity | -2 814 € | -4 400 € | 657 € |
| Employees | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 8 593 € | 81 € | 0 € | - |
| 2025 Q3 | 4 984 € | 492 € | 0 € | - |
| 2025 Q2 | 6 326 € | 710 € | 0 € | - |
| 2025 Q1 | 5 536 € | 812 € | 0 € | - |
| 2024 Q4 | 6 090 € | - | - | - |
| 2024 Q3 | 2 380 € | - | - | - |
| 2024 Q2 | 10 166 € | - | - | - |
| 2024 Q1 | 0 € | - | - | - |
| 2023 Q4 | 0 € | - | - | - |
| 2023 Q3 | 0 € | - | - | - |
| 2023 Q2 | - | - | - | - |
| 2023 Q1 | - | - | - | - |
